The first Evolent Health trade was made in Q2 2018.
Since then Baillie Gifford bought shares four more times and sold shares on two occasions. The investor sold all their shares in Q4 2019 and doesn't own any shares in Evolent Health anymore.
Avg closing price
Price range
Sold -1.08 Million shares
Q4 2019
Avg closing price
$8.12
Price range
$6.49
-
$10.68
Increased shares by 1.1% (+11.6 Thousand shares)
Q3 2019
Avg closing price
$7.18
Price range
$5.82
-
$8.31
Sold 0.1% shares (-967 shares)
Q2 2019
Avg closing price
$11.84
Price range
$7.71
-
$14.54
Increased shares by 4.1% (+42.6 Thousand shares)
Q1 2019
Avg closing price
$15.83
Price range
$12.17
-
$20.92
Increased shares by 2.8% (+27.6 Thousand shares)
Q4 2018
Avg closing price
$23.13
Price range
$17.75
-
$27.20
Increased shares by 15.5% (+135 Thousand shares)
Q3 2018